SCHEMBL1685991

SCHEMBL1685991

CCOC(=O)C(=Cc1ccc(OC)cc1)OC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 2/20 0.50
KMT2A Q03164 5/20 0.49
MAPT P10636 5/20 0.49
MEN1 O00255 4/20 0.49
LMNA P02545 2/20 0.49
NPSR1 Q6W5P4 2/20 0.49
CYP1A2 P05177 2/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
S1PR4 O95977 1/20 0.49
S1PR1 P21453 1/20 0.49
MAPK1 P28482 1/20 0.49
GSK3B P49841 1/20 0.49
CES2 O00748 1/20 0.47
ACHE P22303 1/20 0.47
CES1 P23141 1/20 0.47
NR1H4 Q96RI1 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
GLA P06280 1/20 0.46
KDM4E B2RXH2 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13916941 0.92 MAPT (0.50) ABCG2KMT2AMAPTMEN1LMNA
SCHEMBL6055977 0.92 MAPT (0.50) ABCG2KMT2AMAPTMEN1LMNA
SCHEMBL6055975 0.92 MAPT (0.50) ABCG2KMT2AMAPTMEN1LMNA
SCHEMBL11242541 0.88 GSK3B (0.49) ABCG2KMT2AMAPTMEN1LMNA
Anisaldehyde SCHEMBL7613578 0.87 ALDH1A1 (0.54) ABCG2KMT2AMAPTMEN1LMNA
SCHEMBL5617195 0.86 ABCG2 (0.54) ABCG2KMT2AMAPTMEN1LMNA
SCHEMBL5617197 0.86 ABCG2 (0.54) ABCG2KMT2AMAPTMEN1LMNA
SCHEMBL9568614 0.85 ABCG2 (0.56) ABCG2MAPTNPSR1CYP1A2GSK3B
SCHEMBL18704227 0.85 ABCG2 (0.56) ABCG2MAPTNPSR1CYP1A2GSK3B
SCHEMBL3952982 0.84 MAPT (0.49) KMT2AMAPTMEN1LMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2324863-B1 Method for producing artificial skin SHISEIDO CO LTD (JP) 2013-07-31 EP disclosed
EP-2324863-A1 Method for producing artificial skin SHISEIDO COMPANY, LTD. (JP) 2011-05-25 EP disclosed
US-7927634-B2 Compositions and methods for treating angiogenesis-related diseases, wounds and cosmetic use of components of Angelica sinensis, and methods of preparation thereof SUNNY BIODISCOVERY, INC. (US) 2011-04-19 US disclosed
US-20100255069-A1 COMPOSITIONS AND METHODS FOR TREATING ANGIOGENESIS-RELATED DISEASES, WOUNDS AND COSMETIC USE OF COMPONENTS OF ANGELICA SINENSIS, AND METHODS OF PREPARATION THEREOF SUNNY BIODISCOVERY, INC. (US) 2010-10-07 US disclosed
US-7645595-B2 Method of production of artificial skin SHISEIDO COMPANY, LTD. (JP) 2010-01-12 US disclosed
US-20080248571-A1 Method of Production of Artificial Skin SHISEIDO COMPANY, LTD. (JP) 2008-10-09 US disclosed
US-20080241101-A1 Skin vitalizing composition for external use anti-aging preparation SHISEIDO COMPANY, LTD. 2008-10-02 US disclosed
EP-1066816-B1 AGENTS PROMOTING LAMININ PRODUCTION IN SKIN CELLS SHISEIDO CO LTD (JP) 2007-08-01 EP disclosed
US-20060159782-A1 Material for promoting skin basement formation SHISEIDO COMPANY, LTD. (JP) 2006-07-20 US disclosed
US-20060068032-A1 Compositions and methods for treating angiogenesis-related diseases, wounds and cosmetic use of components of Angelica sinensis, and methods of preparation thereof SUNNY BIODISCOVERY, INC. (US) 2006-03-30 US disclosed
US-20020168425-A1 COLLAGEN PRODUCTION PROMOTER COMPOSITION NAKAYAMA YASUKAZU (JP) 2002-11-14 US disclosed
EP-1180371-A1 AGENTS PROMOTING THE FORMATION OF SKIN BASEMENT MEMBRANE, AGENTS PROMOTING THE FORMATION OF ARTIFICIAL SKIN AND PROCESS FOR PRODUCING ARTIFICIAL SKIN SHISEIDO COMPANY LIMITED (JP) 2002-02-20 EP disclosed
EP-0688559-B1 Skin anti-ageing composition SHISEIDO CO LTD (JP) 2001-06-20 EP disclosed
EP-1066816-A1 AGENTS PROMOTING LAMININ PRODUCTION IN SKIN CELLS SHISEIDO COMPANY LIMITED (JP) 2001-01-10 EP disclosed
US-6077520-A ANTI-AGING TOPICAL COMPOSITION INCLUDING AT LEAST ONE OF SULFONYLETHYLENEAMINE OR MERCAPTOSULFONYLETHYLENEAMINE COMPOUNDS OF GIVEN FORMULA AND SPECIFIED ULTRAVIOLET LIGHT PROTECTIVE AGENTS SHISEIDO COMPANY, LTD. (JP) 2000-06-20 US disclosed
EP-0900561-A1 COMPOSITIONS PROMOTING COLLAGEN PRODUCTION SHISEIDO COMPANY LIMITED (JP) 1999-03-10 EP disclosed
US-5853705-A Anti-aging cosmetic composition SHISEIDO COMPANY, LTD. (JP) 1998-12-29 US disclosed
US-5747049-A AMINOETHYLSULFINIC ACID OR AMINOETHYLTHIOSULFONIC ACID, SUNSCREEN SHISEIDO COMPANY, LTD. (JP) 1998-05-05 US disclosed
EP-0797984-A2 Anti-aging cosmetic composition SHISEIDO COMPANY LIMITED (JP) 1997-10-01 EP disclosed
EP-0688559-A1 Skin anti-ageing composition SHISEIDO COMPANY LIMITED (JP) 1995-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080241101-A1 Skin vitalizing composition for external use anti-aging preparation MMP15, MMP14, SERPINE1 ABCG2 3155/4885KMT2A 3166/4885MAPT 2217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.